Lupin, its JV submit new drug application for Etanercept biosimilar in Japan

Image
Press Trust of India New Delhi
Last Updated : May 08 2018 | 7:05 PM IST

Drug firm Lupin today said its Japanese arm and
Lupin MD Nilesh Gupta said: "The application for Etanercept biosimilar is a significant milestone for Lupin as we build our biosimilars pipeline."

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: May 08 2018 | 7:05 PM IST

Next Story